Considerations in the design of clinical trials for pediatric acute lymphoblastic leukemia

Author： Devidas Meenakshi   Anderson James R  

Publisher： Future Science

ISSN： 2041-6792

Source： Clinical Investigation, Vol.3, Iss.9, 2013-09, pp. : 849-858

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment and biology of pediatric acute lymphoblastic leukemia

By  

PEDIATRICS INTERNATIONAL, Vol. 60, Iss. 1, 2018-01 ,pp. : 4-12

John Wiley & Sons Inc

Access to resources Recommend Favorite

Future perspectives on minimizing bone density reduction in pediatric acute lymphoblastic leukemia

By Winkel Mariël Lizet te   Pieters Rob   van den Heuvel-Eibrink Marry M  

Personalized Medicine, Vol. 7, Iss. 5, 2010-09 ,pp. : 469-471

Future Medicine

Access to resources Recommend Favorite

Cortical surface area and thickness in adult survivors of pediatric acute lymphoblastic leukemia

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 6, 2015-06 ,pp. : 1027-1034

John Wiley & Sons Inc

Access to resources Recommend Favorite

Obesity is an important health problem in survivors of pediatric acute lymphoblastic leukemia

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 1545-5009, Iss. 11, 2015-11 ,pp. : 2058-2059

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reply to: Obesity is an important health problem in survivors of pediatric acute lymphoblastic leukemia

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 1545-5009, Iss. 11, 2015-11 ,pp. : 2057-2057

John Wiley & Sons Inc

Access to resources Recommend Favorite